In this study, a novel molecular mechanism for ACK1 in cancer progression was elucidated in GC, a non-hormone-driven cancer, whereby ACK1 promotes tumor growth, survival and colony formation through an ECD-dependent p53 ubiquitination degradation. Here, TP53 is linked to cancer.